-
Healthy Habits
Another Reason to FlossGum disease is associated with increased cancer risk.
by Kendall K. Morgan
-
Q&A
Why Fat MattersCancer epidemiologist Cornelia Ulrich discusses research that explores how fat cells and cancer cells communicate.
by Marci A. Landsmann
-
A New Guideline for Cervical Cancer Screening
Physicians Lee Learman and Francisco Garcia discuss the updated U.S. Preventive Services Task Force guideline and the need to increase access to cervical cancer screening.
by Anna Azvolinsky
-
Study Shows Minority Participation in Clinical Trials May Be Declining
Researcher speculates that costly genetic testing may be limiting outreach to underserved communities.
by Marci A. Landsmann
-
From the Editor-in-Chief
Metabolism and CancerCan cancer's dependence on sugar help researchers find new targets to treat the disease?
by William G. Nelson, MD, PhD
-
Forward Look
Your Tax Dollars at WorkQ&A with Joseph Unger on publicly funded cancer research.
by Sue Rochman
-
Forward Look
Opportunities for PreventionInteractive maps and charts illustrate how many cancers are caused by infections worldwide.
by Sue Rochman
-
Some Pancreatic Cancers Are Hereditary
A trio of recent studies indicates that pancreatic cancer is, in some cases, linked to mutations passed down from generation to generation.
by Cheryl Platzman Weinstock
-
Vaccines: Looking Within for Cancer Treatment
Researchers are testing treatment vaccines that spur the immune system to attack cancer.
by Stephen Ornes
Cancer Talk
The Impact of the RACE for Children Act
Legislation to speed cancer drug development for children and adolescents requires drug companies to test drugs in children, but trials in people under 18 may take years to generate results.
by Marci A. Landsmann
Understanding Stress and CancerA symposium at the AACR Annual Meeting explores how social factors contribute to elevated risk of cancer in some populations.
by Eric Fitzsimmons
Exploring Amino Acids’ Impact on Tumor GrowthResearchers are investigating how to match specific dietary changes with therapy to impede cancer progression.
by Thomas Celona
Study Shows Minority Participation in Clinical Trials May Be DecliningResearcher speculates that costly genetic testing may be limiting outreach to underserved communities.
by Marci A. Landsmann
